<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> is a complex disease which includes many pathologies featuring abnormal growth of healthy cells, invasion and metastization </plain></SENT>
<SENT sid="1" pm="."><plain>Cellular uncontrolled growth increases the amount of abnormal cells, these cells reach the blood stream and other healthy tissues giving rise to <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Even though great progresses have been made in understanding <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> aetiology and in the development of new anticancer drugs, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> still remains one of the leading causes of <z:hpo ids='HP_0011420'>death</z:hpo> worldwide </plain></SENT>
<SENT sid="3" pm="."><plain>Most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> include <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:e sem="disease" ids="C0153633" disease_type="Neoplastic Process" abbrv="">brain cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Conventional chemotherapeutics have proven to be inefficient in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatment due to lack of specificity and poor drug accumulation in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, they cause severe side effects </plain></SENT>
<SENT sid="6" pm="."><plain>Available treatments must be prolonged on time to achieve some therapeutic effect; however, this often leads to the development of multidrug resistance by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>Nanotechnology platforms are, therefore, being exploited as potential alternatives </plain></SENT>
<SENT sid="8" pm="."><plain>Nanosystems have been reported to target and deliver the drug in situ to selectively kill <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, decreasing toxicity on healthy organs and tissues as well as side effects </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, some nanosystems have been reported to overcome <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> resistance, at least to some extent </plain></SENT>
<SENT sid="10" pm="."><plain>Over the years several nanosystems have been proposed to diagnose and treat <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, such as <z:chebi fb="0" ids="51338">dendrimers</z:chebi>, polymeric micelles, superparamagnetic <z:chebi fb="27" ids="50820">iron oxide</z:chebi> cores, <z:chebi fb="0" ids="50825">gold nanoparticles</z:chebi>, liposomes and other <z:chebi fb="23" ids="18059">lipid</z:chebi> nanoparticles </plain></SENT>
<SENT sid="11" pm="."><plain>Due to their small size and biocompatibility, they can reach the target site without being detected by the immune system and suffer cellular uptake or deliver the drug in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> vicinity </plain></SENT>
</text></document>